Aortic Dissection

Published on 07/03/2015 by admin

Filed under Critical Care Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1469 times

Chapter 30 Aortic Dissection

4 What is the epidemiology of dissection, including mortality?

Aortic dissection is a relatively rare but a highly lethal disease. The estimated incidence is 5 to 30 cases per million people per year. Population-based studies suggest that the incidence of acute dissection ranges from 2 to 3.5 cases per 100,000 person-years, which correlates with 6000 to 10,000 cases annually in the United States. It may be that two to three times as many patients die of dissections as of ruptured aortic aneurysms; approximately 75% of patients with ruptured aortic aneurysm will reach an emergency department alive, whereas for aortic dissection 40% die immediately. Furthermore, only 50% to 70% will be alive 5 years after surgery depending on age and underlying cause.

For untreated acute dissection of the ascending aorta the mortality rate is 1% to 2% per hour after onset. For type A dissections treated medically it is approximately 20% within the first 24 hours and 50% by 1 month after presentation. Even with surgical intervention, the mortality rate for type A dissection may be as high as 10% after 24 hours and nearly 20% 1 month after repair.

Although type B dissection is less dangerous than type A, it is still associated with an extremely high mortality. The 30-day mortality rate for an uncomplicated type B dissection approaches 10%. However, patients with type B dissection who have complications such as limb ischemia, renal failure, or visceral ischemia have a 2-day mortality upwards of 20% and may prompt the need for surgical intervention.

5 What are the risk factors and associated conditions for dissection?

The prevalence of aortic dissection appears to be increasing, independent of the aging population, as noted by Olsson and colleagues, who found that the incidence of dissection among Swedish men has increased to 16 per 100,000 yearly. Risk factors include the following:

image Hypertension: Present in 70% to 90% of patients with acute dissection.

image Advanced age: Mean of 63 years in the International Registry of Acute Aortic Dissection (IRAD).

image Male sex: Represented by 65% of patients in the IRAD.

image Family history: Recently recognized is a genetic, nonsyndromic familial form of thoracic aortic dissection. Studies of patients referred for repair of thoracic aortic dissections and aneurysms who did not have a known genetic mutation have indicated that between 11% and 19% of these patients have a first-degree relative with thoracic aortic disease.

image Trauma (deceleration/torsional injury)

image Congenital and inflammatory disorders: present as Marfan syndrome in almost 5% of total patients in the IRAD and half of those patients under age 40 years. Other associated congenital disorders include Ehlers-Danlos syndrome, Loeys-Dietz syndrome, bicuspid aortic valve, aortic coarctation, Turner syndrome, Takayasu and giant-cell aortitis, relapsing polychondritis (Behçet disease, spondyloarthropathies), or confirmed genetic mutations known to predispose to dissections (TGFBR1, TGFBR2, FBN1, ACTA2, or MYH11).

image Pregnancy: Associated with 50% of dissections in women under age 40 and most frequently occurring in the third trimester. This might be attributable to elevations in cardiac output during pregnancy that cause increased wall stress.

image Circadian and seasonal variations: Producing a higher frequency of dissection in the morning hours and in the winter months.

image Iatrogenic: Occurring as a consequence of invasive procedures or surgery, especially when the aorta has been entered or its main branches have been cannulated, such as for cardiopulmonary bypass.

7 Describe the common clinical findings associated with aortic dissection

A systems-based approach can be used to describe the wide range of clinical findings that can be associated with aortic dissection.

image Neurologic symptoms. The reported frequency of neurologic symptoms in pooled data of type A and B dissections approaches 17%; in type A alone, 29% of patients were seen initially with neurologic symptoms, 53% of which represented ischemic stroke. Neurologic complications may result from hypotension, malperfusion, distal thromboembolism, or nerve compression. Acute paraplegia as a result of spinal cord malperfusion has been described as a primary manifestation in 1% to 3% of patients. Up to 50% of neurologic symptoms may be transient.

image Cardiovascular manifestations. The heart is the most frequently involved end-organ in acute proximal aortic dissections.

image Peripheral vascular complications can manifest as pulse and/or blood pressure differentials or deficits and occur in approximately one third to one half of patients with proximal dissection. Etiology is partial compression, obstruction, thrombosis, or embolism of the aortic branch vessels, resulting in cerebral, renal, visceral, or limb ischemia. Peripheral pulse deficits should alert the clinician to possible ongoing renal or visceral ischemia unable to be detected from physical examination or laboratory values alone.

image Pulmonary complications may manifest as pleural effusions, which occur most frequently on the left. Causes include rupture of the dissection into the pleural space or weeping of fluid from the aorta as an inflammatory response to the dissection.

9 Describe imaging modalities used to diagnose aortic dissection

In 2010, the American Heart Association and American College of Cardiology released guidelines for the diagnosis and management of patients with thoracic aortic disease, which identified high-risk clinical features to assist in the early detection of acute aortic dissection. On the basis of clinical risk factors and conditions, presentation, and associated examination findings, patients are stratified into low-, intermediate-, or high-risk categories. Further work-up is dictated by this pretest probability index. Some patients with acute dissection initially have no high-risk features, creating a diagnostic dilemma. According to most recent guidelines, if a clear alternative diagnosis is not established after the initial evaluation, then obtaining a diagnostic aortic imaging study should be considered.

Although lacking specificity, a chest radiograph should be obtained as part of the initial diagnostic evaluation. A radiograph abnormality is seen in up to 90% of patients with aortic dissection; most frequent is widening of the aorta and mediastinum. Other findings may include a localized hump on the aortic arch, displacement of calcification in the aortic knob, and pleural effusions. However, approximately 40% of radiographs in acute dissection lack a widened mediastinum, and as many as 16% are normal. Thus a negative radiograph must not delay definitive aortic imaging in patients deemed at high risk for aortic dissection by initial screening.

Computed tomography (CT) scanning, magnetic resonance imaging (MRI), and transesophageal echocardiography (TEE) are all highly accurate imaging modalities that may be used to make the diagnosis; all can provide acceptable diagnostic accuracy. Transthoracic echocardiography has limited diagnostic accuracy. Aortography, which was once the test of choice, is no longer used routinely because it is invasive and time-consuming and involves exposure to intravenous contrast dye. The most recent comparative study with nonhelical CT, MRI, and TEE showed 100% sensitivity for all modalities, with better specificity of CT (100%) as compared with TEE or MRI. A recent meta-analysis found that all three imaging techniques provided equally reliable results. Although each imaging modality offers advantages and disadvantages, the choice among CT, MRI, and TEE is probably best based on which is most readily available. It should be noted, however, that the diagnosis of acute aortic dissection can be difficult and occasionally cannot be absolutely excluded by a single imaging study. If a high clinical suspicion exists despite initially negative imaging, then consideration should be given to a second imaging modality. Regardless, prompt surgical consultation should be initiated in any patient with a suspected dissection.

12 What are the strategies for medical management of dissection and commonly used medications?

The goals of medical therapy are to treat pain, to aggressively control blood pressure, and to determine need for surgical or endovascular intervention. Patients who are seen with hypotension should receive the following:

In those who are seen initially with hypertension, the blood pressure should generally be lowered to a systolic of 100 to 120 mm Hg, to a mean of 60 to 65 mm Hg, or to the lowest level that is compatible with perfusion of the vital organs. The aortic wall stress is affected by the heart rate, blood pressure, and velocity of ventricular contraction (dP/dt).

The ideal antihypertensive regimen must decrease blood pressure without increasing cardiac output through peripheral vasodilatation. This is because an increased cardiac output can increase flow rates producing higher aortic wall stress and thus propagating the dissection. Intravenous β-blockers (commonly esmolol, labetalol, propranolol, or metoprolol) are considered the first-line medical stabilization regimen because they affect all three parameters without increases in cardiac output and aortic wall stress. In patients who are unable to tolerate β- blockade, nondihydropyridine calcium channel antagonists (verapamil, diltiazem) offer an acceptable alternative.

Often, single-drug therapy alone is inadequate to optimize blood pressure management. Adequate pain control is essential not only for patient comfort but also to decrease sympathetic-mediated increases in heart rate and blood pressure. This may be accomplished with intravenous opioid analgesics. If β-blockade and adequate pain control are ineffective to control blood pressure, the addition of a rapidly acting, easily titratable intravenous vasodilator, such as nitroprusside, should be considered. Other agents, such as nicardipine, nitroglycerin, and fenoldopam, are also acceptable. Vasodilator therapy without prior β-blockade may cause reflex tachycardia and increased force of ventricular contraction leading to greater wall stress and potentially causing false lumen propagation; therefore adequate β-blockade must be established first, before the vasodilator is initiated.

Bibliography

1 Akin I., Kische S., Rehders T.C., et al. Thoracic endovascular stent-graft therapy in aortic dissection. Curr Opin Cardiol. 2010;25:552–559.

2 Clouse W.D., Hallett J.W.Jr. Schaff HV, et al: Acute aortic dissection: population-based incidence compared with degenerative aortic aneurysm rupture. Mayo Clin Proc. 2004;79:176–180.

3 Eggebrecht H., Nienaber C., Neuhauser M., et al. Endovascular stent-graft placement in aortic dissection: a meta-analysis. Eur Heart J. 2006;27:489–498.

4 Ehrlich M.P., Dumfarth J., Schoder R., et al. Midterm results after endovascular treatment of acute, complicated type B aortic dissection. Ann Thorac Surg. 2010;90:1444–1448.

5 Estrera A.L., Miller C.C.III. Safi HJ, et al: Outcomes of medical management of acute type B aortic dissection. Circulation. 2006;114(Suppl 1):I384–I389.

6 Hagan P.G., Nienaber C.A., Isselbacher E.M., et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA. 2000;283:897–903.

7 Hiratzka L.F., Bakris G.L., Beckman J.A., et al. 2010 CCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease. Circulation. 2010;121:e266–e369.

8 Khoynezhad A., Plestis K.A. Managing emergency hypertension in aortic dissection and aortic aneurysm surgery. J Card Surg. 2006;21(Suppl 1):S3–S7.

9 Leurs L.J., Bell R., Degrieck Y., et al. Endovascular treatment of thoracic aortic diseases: combined experience from the EUROSTAR and United Kingdom Thoracic Endograft registries. J Vasc Surg. 2004;40:670–680.

10 Nienaber C., Rousseau H., Eggebrecht H. Randomized comparison of strategies for type-B aortic dissection. The Investigation of Stent Grafts in Aortic Dissection (INSTEAD) trial. Circulation. 2009;120:2519–2528.

11 Olsson C., Thelin S., Stahle E., et al. Thoracic aortic aneurysm and dissection: increasing prevalence and improved outcomes reported in a nationwide population-based study of more than 14,000 cases from 1987 to 2002. Circulation. 2006;114:2611–2618.

12 Parsa C.J., Schroder J.N., Daneshmand M.A., et al. Midterm results for endovascular repair of complicated acute and chronic type B aortic dissection. Ann Thorac Surg. 2010;89:97–102.

13 Trimarchi S., Nienaber C.A., Rampoldi V., et al. Role and results of surgery in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation. 2006;14(Suppl 1):I357–I364.

14 Yagdi T., Atay Y., Engin C., et al. Impact of organ malperfusion on mortality and morbidity in acute type A aortic dissections. J Card Surg. 2006;21:363–369.

15 Zoli S., Etz C.D., Roder F., et al. Long-term survival after open repair of chronic distal aortic dissection. Ann Thorac Surg. 2010;89:1458–1466.